Gsk agrees to pay $460 million to resolve lawsuits
GSK agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, sources said.
GE Healthcare has agreed to pay $30 million in a settlement involving the Justice Department over claims in a case filed by a Michigan salesman.